AUA 2006 News - UrologyTimes
Urology Times

ADVERTISEMENT

AUA 2006 News

Combination therapy improves both LUTS and ED

May 24, 2006

Combining the alpha-blocker alfuzosin SR (Uroxatral) with the phosphodiesterase type-5 inhibitor sildenafil citrate (Viagra) appears to produce a greater therapeutic benefit in men with lower urinary tract symptoms than either drug alone, researchers said yesterday.

Dr. Flanigan is named new AUA secretary

May 24, 2006

Robert C. Flanigan, MD, was named the new secretary of AUA during the association's business meeting yesterday. He is professor and chair of urology at the Loyola University Health System, Maywood, IL.

Study suggests PDE-5 inhibitor improves LUTS in men with BPH

May 24, 2006

Once-a-day tadalafil (Cialis) at dosages ranging from 5 mg to 20 mg produces measurable benefits in men with BPH and lower urinary tract symptoms, according to a multicenter study presented here yesterday.

Older men and ED drugs: Interest and use are low

May 24, 2006

Despite media images depicting middle-aged and older men embracing the use of phosphodiesterase type-5 inhibitors to correct erectile dysfunction, actual interest and usage in this population is unknown.

New biomaterial launched for treatment of Peyronie's disease

May 24, 2006

Cook Urological introduced on Tuesday a new biomaterial known as Surgisis ES for the treatment of Peyronie's disease. Surgisis ES is a natural biomaterial that provides a graft that is strong, easy to handle, easy to use, and biocompatible, the company said. It supports the growth of new fully vascularized host tissue in the penis.

Botulinum toxin shows sustained, positive effects in BPH

May 24, 2006

Intraprostatic injection of botulinum toxin type A (Botox) is a safe and effective treatment in patients with symptomatic BPH that results in improvements in symptoms and quality of life that may persist for up to 1 year, researchers from Taiwan said.

Infertility affects patients mentally as well as physically

May 24, 2006

Two separate studies have found that men and women dealing with infertility suffer from depression and anxiety at a greater rate than the general population.

Long-term survival impressive for inflatable penile prostheses

May 23, 2006

Long-term survival of inflatable penile prostheses (IPPs) that have been in use over the past 2 decades is excellent, and the reliability of those devices appears even more promising for the enhanced models that have become more recently available, said Steven K. Wilson, MD.

Pudendal nerve stimulation may be alternative to sacral neuromodulation

May 23, 2006

Stimulation of the pudendal nerve may be an alternative to sacral neurostimulation (SNS) in the treatment of urinary voiding dysfunction. Two studies presented yesterday indicate that pudendal neurostimulation (PNS) is effective in patients who do not respond to SNS.

Urology Times E-News

Brings you the latest news and information twice each month.

Click here to view the E-News archives.

Sign up now to receive Urology Times E-news free of charge!

Practice ToolsPractice Tools
Coding Counselor
Coding Counselor

Simple and accurate ICD-9 code search. Start Here

Formulary Counselor
Formulary Counselor

Find health plan drug coverage in your area. Start Here

Patient Education
Patient Education

Print customized patient education handouts. Start Here

Surgical Video Center
Surgical Video Center

On-demand surgery demos and presentations. Start Here

ADVERTISEMENT



Click here